Cholinergic modulation of microglial activation by α7 nicotinic receptors

Journal of Neurochemistry

Volumn 89, Issue 2, 2004, Pages 337-343

  Shytle, R Douglas ^a   Mori, Takashi ^b   Townsend, Kirk ^a   Vendrame, Martina ^a   Sun, Nan ^a   Zeng, Jin ^a   Ehrhart, Jared ^a   Silver, Archie A ^a   Sanberg, Paul R ^a   Tan, Jun ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Department of Neurology   (Japan)

Author keywords

7; Acetylcholine; LPS (lipopolysaccharide); MAPK (mitogen activated protein kinase); Microglia; Nicotine

Indexed keywords

ALPHA BUNGAROTOXIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINE; NICOTINIC RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CHOLINERGIC SYSTEM; IMMUNOCYTOCHEMISTRY; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ACETYLCHOLINE; ANIMALS; BUNGAROTOXINS; CELLS, CULTURED; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NICOTINE; NICOTINIC ANTAGONISTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE;

EID: 11144355227     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2004.02347.x     Document Type: Article

References (36)

1. Albright A. V., Martin J., O'Connor M. and Gonzalez-Scarano F. (2001) Interactions between HW-1 gp120, chemokines, and cultured adult microglial cells. J. Neurovirol. 7, 196-207.
2. Belluardo N., Mudo G., Blum M. and Fuxe K. (2000) Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res. 113, 21-34.
3. Brenner D. E., Kukull W. A., van Belle G., Bowen J. D., McCormick W. C., Teri L. and Larson E. B. (1993) Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43, 293-300.
4. Burghaus L., Schutz U., Krempel U., de Vos R. A., Jansen Steur E. N., Wevers A., Lindstrom J. and Schroder H. (2000) Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res. Mol. Brain Res. 76, 385-388.
5. Cormier A., Morin C., Zini R., Tillement J. P. and Lagrue G. (2003) Nicotine protects rat brain mitochondria against experimental injuries. Neuropharmacology 44, 642-652.
6. 2+ stores. J. Neurochem. 81, 606-614.
7. Engidawork E., Gulesserian T., Balic N., Caims N. and Lubec G. (2001) Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease. J. Neural Transm. Suppl., 211-222.
8. Fiebich B. L., Lieb K., Engels S. and Heinrich M. (2002) Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J. Neuroimmunol. 132, 18-24,
9. Ghosheh O. A., Dwoskin L. P., Miller D. K. and Crooks P. A. (2001) Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2′-(14) C]nicotine. Drug Metab. Disposition 29, 645-651.
10. Guan Z. Z., Nordberg A., Mousavi M., Rinne J. O. and Hellstrom-Lindahl E. (2002) Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease. Brain Res. 956, 358-366.
11. Guan Z. Z., Yu W. F. and Nordberg A. (2003) Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem. Int. 43, 243-249.
12. Hilmas C., Pereira E. F., Alkondon M., Rassoulpour A., Schwarcz R. and Albuquerque E. X. (2001) The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21, 7463-7473.
13. Jeohn G. H., Cooper C. L., Jang K. J., Liu B., Lee D. S., Kim H. C. and Hong J. S. (2002) Go6976 inhibits LPS-induced microglial TNFα release by suppressing p38 MAP kinase activation. Neuroscience 114, 689-697.
14. 2+ signaling and down-regulation of nicotinic acetylcholine receptor subunit expression in the CEM human leukemic T-cell line. Life Sci. 72, 2155-2158.
15. Kuo Y., Lucero L., Michaels J., DeLuca D. and Lukas R. J. (2002) Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus. J. Neuroimmunol. 130, 140-154.
16. Leonard S., Breese C., Adams C. et al. (2000) Smoking and schizophrenia: abnormal nicotinic receptor expression. Eur J. Pharmacol. 393, 237-242.
17. Liu B. and Hong J. S. (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1-7.
18. Morens D. M., Grandinetti A., Reed D., White L. R. and Ross G. W. (1995) Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology 45, 1041-1051.
19. Newhouse P. A., Potter A. and Levin E. D. (1997) Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11, 206-228.
20. Newman M. B., Arendash G. W., Shytle R. D., Bickford P. C., Tighe T. and Sanberg P. R. (2002) Nicotine's oxidative and antioxidant properties in CNS. Life Sci. 71, 2807-2820.
21. Nordberg A., Alafuzoff I. and Winblad B. (1992) Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31, 103-111.
22. O'Neill M. J., Murray T. K., Lakics V., Visanji N. P. and Duty S. (2002) The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr. Drug Target CNS Neurol. Disord. 1, 399-411.
23. Perry D. C., Davila-Garcia M. I., Stockmeier C. A. and Kellar K. J. (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289, 1545-1552.
24. Polazzi E. and Contestabile A. (2002) Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev. Neurosci. 13, 221-242.
25. Shytle R. D., Baker M., Silver A. A., Soloman M. and Sanberg P. R. (2000) Smoking, nicotine, and movement disorders. Nicotine in Psychiatry: Psychopathology and Emerging Therapeutics, pp. 183-202. APA Press, Halifax, Canada.
26. Streit W. J. (2000) Microglial response to brain injury: a brief synopsis. Toxicol. Pathol. 28, 28-30.
27. Streit W. J. and Sparks D. L. (1997) Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J. Mol. Med. 75, 130-138.
28. Tan J., Town T., Paris D. et al. (1999a) Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation. Science 286, 2352-2355.
29. Tan J., Town T., Saxe M., Paris D., Wu Y. and Mullan M. (1999b) Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-α production that is opposed by TGF-beta 1 and IL-10. J. Immunol. 163, 6614-6621.
30. Tan J., Town T., Mori T., Wu Y., Saxe M., Crawford F. and Mullan M. (2000b) CD45 opposes β-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J. Neurosci. 20, 7587-7594.
31. Tan J., Town T. and Mullan M. (2000a) CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J. Biol. Chem. 275, 37224-37231.
32. Tan J., Town T. and Mullan M. (2002) CD40-CD40L interaction in Alzheimer's disease. Curr. Opin. Pharmacol. 2, 445-451.
33. Terry A. V. Jr and Buccafusco J. J. (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306, 821-827.
34. Wang H., Yu M., Ochani M. et al. (2003) Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384-388.
35. Wenk G. L., McGann K., Mencarelli A., Hauss-Wegrzyniak B., Del Soldato P. and Fiorucci S. (2000) Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons. Eur. J. Pharmacol. 402, 77-85.
36. Wessler I., Reinheimer T., Klapproth H., Schneider F. J., Racke K. and Hammer R. (1997) Mammalian glial cells in culture synthesize acetylcholine. Naunyn Schmiedebergs Arch. Pharmacol. 356, 694-697.